Related Experiment Videos
Can lowering homocysteine levels reduce the incidence of stroke?
1Department of Medicine, Good Hope Hospital, West Midlands, U.K.
Journal of Clinical Pharmacy and Therapeutics
|December 3, 1999
Insights
High homocysteine levels (hyperhomocysteinaemia) are a significant risk factor for stroke and other vascular diseases. This review examines the impact of elevated plasma homocysteine on stroke disease.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Clinical Biochemistry
Background:
- Hyperhomocysteinaemia is an independent risk factor for vascular diseases.
- Atherosclerotic and thromboembolic conditions are linked to elevated homocysteine.
- Stroke disease is a major concern in cardiovascular and neurological health.
Purpose of the Study:
- To review the role of high plasma homocysteine levels in stroke disease.
- To consolidate current understanding of hyperhomocysteinaemia's impact on cerebrovascular events.
Main Methods:
- Literature review of studies investigating homocysteine and stroke.
- Analysis of epidemiological and clinical data on hyperhomocysteinaemia.
- Synthesis of evidence linking plasma homocysteine to stroke pathology.
Main Results:
- Elevated homocysteine is associated with increased risk of stroke.
- Mechanisms include endothelial dysfunction, inflammation, and thrombosis.
- Specific thresholds of homocysteine may correlate with stroke risk.
Conclusions:
- High plasma homocysteine is a modifiable risk factor for stroke.
- Management of hyperhomocysteinaemia may reduce stroke incidence.
- Further research is warranted to optimize therapeutic strategies.
Abstract:
Hyperhomocysteinaemia has been identified as an independent risk factor for atherosclerotic and thromboembolic diseases such as cerebro-vascular diseases, coronary artery disease and venous thrombosis. This review will discuss the role of high levels of plasma homocysteine in stroke disease.